Mollie Wood
@anecdatally.bsky.social
1.5K followers 370 following 98 posts
Asst. prof of epidemiology at UNC Chapel Hill | training at HSPH, UiO, UMass Med, BUSPH | interests in rxepi, repro-perinatal epi, methods | she/her/dr
Posts Media Videos Starter Packs
anecdatally.bsky.social
Weekly Ruport: bad news cycle means more emotional support pillows
A picture of a chocolate labrador curled up on a pile of throw pillows and looking sleepily at the camera
anecdatally.bsky.social
As a post script, I also want to say that I find the “medically necessary” language around APAP use ridiculous and insulting. Do they think pregnant women are taking acetaminophen for fun? Or mistaking the pills for candy?
anecdatally.bsky.social
You wouldn’t know it from this thread, but other people have opinions about APAP in pregnancy and neurodevelopmental outcomes. @perdamkier.bsky.social in particular has written a lot about the topic, including this piece: onlinelibrary.wiley.com/doi/10.1111/...
Annotations and Reflections
Click on the article title to read more.
onlinelibrary.wiley.com
anecdatally.bsky.social
...for specific conditions during pregnancy. Active comparator designs would strengthen these types of studies significantly, particularly for conditions where “no treatment” is not a realistic or ethical recommendation.
anecdatally.bsky.social
People taking high doses of APAP for long periods of time aren’t irresponsible, they’re desperate. Most frustratingly, APAP isn’t a particularly good drug for chronic pain conditions. All of which is to say: I think research needs to focus more on comparing clinically meaningful treatments...
anecdatally.bsky.social
My pet hypothesis, for which I only have indirect evidence, is something like this: I think it is possible that very high doses of APAP over extended periods of time (i.e., 500+mg daily for multiple weeks) could cause neurodevelopmental differences in exposed fetuses.
anecdatally.bsky.social
Why is acetaminophen so hard to study? Reason 4: dose, duration, and timing of use are likely important, which amplifies the measurement problem (Reason 1), makes the confounding problem worse (Reason 2), and is further hampered by the selection problem (Reason 3).
anecdatally.bsky.social
...how do we think about the counterfactual here? The children with prenatal APAP exposure might not have been born, had their parent not used APAP.
anecdatally.bsky.social
Why is acetaminophen so hard to study? Reason 3: studies of neurodevelopment almost always condition on a live birth. But untreated fever in early pregnancy can lead to miscarriage, so...
anecdatally.bsky.social
...much of the use for pain conditions is among people who were managed on a different (more effective) drug before pregnancy and then switched when they became pregnant.
anecdatally.bsky.social
Why is acetaminophen so hard to study? Reason 2: there is a huge range of reasons for using APAP, all of which have different relationships with neurodevelopment. People take APAP for pain and fever, yes, but...
anecdatally.bsky.social
Some studies have used biomarkers (urine, meconium), but APAP is metabolized quickly so these measures are only a snapshot for specific time windows.
anecdatally.bsky.social
Why is acetaminophen so hard to study? Reason 1: it’s hard to measure. Acetaminophen (APAP) is available over the counter and by prescription, alone or in combination with other medications. Studies often rely on parental recall, which varies in accuracy, or prescription fills, which miss OTC use.
anecdatally.bsky.social
I’ve also written a commentary about some of the challenges (posted here by @dremilyrsmith.bsky.social ) bsky.app/profile/drem...
dremilyrsmith.bsky.social
For you epi nerds inspired to brush up on analytical challenges in perinatal pharmacoepidemiology, here is a nice piece from @anecdatally.bsky.social!

Associations between prenatal acetaminophen exposure & child neurodevelopment: Truth, bias, or a bit of both? pmc.ncbi.nlm.nih.gov/articles/PMC...
Associations between prenatal acetaminophen exposure and child neurodevelopment: Truth, bias, or a bit of both?
pmc.ncbi.nlm.nih.gov
anecdatally.bsky.social
I’ve published 2 papers on acetaminophen in pregnancy and neurodevelopmental outcomes, both as methods supervisor for a doctoral student who was the first author, from the MoBa study. I’ll drop the links at the end of the thread- both are open access either via PMC or the journal website.
anecdatally.bsky.social
It’s hard to know whether talking about these things is helpful or just gives them more oxygen, but the current acetaminophen fire is already roaring so here we go. Most importantly: ACOG affirms their position that acetaminophen is safe in pregnancy bsky.app/profile/acog...
"In more than 2 decades of research on the use of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the use of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in children." -ACOG President Steven J. Fleischman, MD, MBA, FACOG
anecdatally.bsky.social
...either pull the (accepted!!) paper and resubmit somewhere with free open access, or self-archive the submitted version of the manuscript (essentially a post hoc preprint) to PMC and then update to accepted version after embargo. Any other options I'm not considering? What have others done? (3/3)
anecdatally.bsky.social
...but there was no budget in the F for OA fees (and the T32 no longer exists 😢). Asked journal to waive OA fee given circumstances (nope), looked for institution funding to support (lol). I think the remaining options are... (2/3)
anecdatally.bsky.social
I'm hoping for advice from NIH funded researchers re the updated OA policy (grants.nih.gov/grants/guide...). Specifically: I have students funded on an F31 or T32 whose papers were submitted this spring and accepted after 7/1. Per policy, those papers must be OA from pub date... (1/3)
NOT-OD-25-101: Revision: Notice of Updated Effective Date for the 2024 NIH Public Access Policy
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Revision: Notice of Updated Effective Date for the 2024 NIH Public Access Policy NOT-OD-25-101. NIH
grants.nih.gov
Reposted by Mollie Wood
vikilovesfacs.bsky.social
Props to the CDC staff who presented the science at yesterday’s #ACIP meeting.

Key points relating to #CovidVaccination in #pregnancy

1. No increased risk of any problems in pregnancy, at birth, or for infants

1/

www.cdc.gov/acip/downloa...
A slide presented at the 18 September ACIP meeting (linked in the post). Links to CDC run studies on COVID vaccine safety in pregnancy. A list of outcomes not associated with COVID vaccination in pregnancy in these studies, including miscarriage, stillbirth, preterm birth, major birth defects, maternal or infant ICU admission.
anecdatally.bsky.social
Euler diagrams, maybe, from someone who said "you-ler" for an embarrassingly long time?